LianBio (LIAN) Short Interest Ratio & Short Volume → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free LIAN Stock Alerts $0.28 -0.02 (-6.65%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media LianBio Short Interest DataCurrent Short Volume378,100 sharesPrevious Short Volume568,800 sharesChange Vs. Previous Month-33.53%Dollar Volume Sold Short$1.83 millionShort Interest Ratio / Days to Cover0.7Last Record DateFebruary 29, 2024Outstanding Shares108,063,000 sharesFloat Size104,770,000 sharesShort Percent of Float0.36%Today's Trading Volume10,871 sharesAverage Trading Volume1,037,083 sharesToday's Volume Vs. Average1% Short Selling LianBio ? Sign up to receive the latest short interest report for LianBio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLIAN Short Interest Over TimeLIAN Days to Cover Over TimeLIAN Percentage of Float Shorted Over Time Ad True Market InsidersThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 LianBio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/29/2024378,100 shares $1.83 million -33.5%0.4%0.7 $4.84 2/15/2024568,800 shares $2.72 million +144.3%0.5%1.1 $4.78 1/31/2024232,800 shares $956,808.00 -87.1%0.2%0.9 $4.11 1/15/20241,800,000 shares $7.47 million +40.6%1.7%0.7 $4.15 12/31/20231,280,000 shares $5.72 million +19.6%1.2%0.5 $4.47 12/15/20231,070,000 shares $4.50 million -6.1%1.0%0.4 $4.21 Get the Latest News and Ratings for LIAN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LianBio and its competitors with MarketBeat's FREE daily newsletter. 11/30/20231,140,000 shares $4.65 million -10.9%1.1%0.5 $4.08 11/15/20231,280,000 shares $5.12 million -49.0%1.2%0.5 $4.00 10/31/20232,510,000 shares $10.17 million +12,838.1%2.4%1.1 $4.05 10/15/202319,400 shares $27,354.00 -30.2%0.0%0 $1.41 9/30/202327,800 shares $41,422.00 -12.3%0.0%0.1 $1.49 9/15/202331,700 shares $50,720.00 -85.4%0.0%0.2 $1.60 8/31/2023216,900 shares $394,758.00 +38.2%0.2%1 $1.82 8/15/2023157,000 shares $298,300.00 +306.7%0.2%0.7 $1.90 7/31/202338,600 shares $77,200.00 +1.1%0.0%0.1 $2.00 7/15/202338,200 shares $90,152.00 -62.5%0.0%0.2 $2.36 6/30/2023101,800 shares $232,104.00 -54.9%0.1%0.5 $2.28 6/15/2023225,600 shares $586,560.00 +193.4%0.2%1.1 $2.60 5/31/202376,900 shares $192,250.00 -48.1%0.1%0.3 $2.50 5/15/2023148,200 shares $321,594.00 -18.6%0.1%0.6 $2.17 4/30/2023182,100 shares $406,083.00 +41.1%0.2%0.8 $2.23 4/15/2023129,100 shares $290,475.00 -8.3%0.1%0.7 $2.25 3/31/2023140,800 shares $275,968.00 -13.8%0.1%0.6 $1.96 3/15/2023163,300 shares $271,894.50 -3.0%0.2%0.7 $1.67 2/28/2023168,300 shares $311,355.00 +36.1%0.2%0.8 $1.85 2/15/2023123,700 shares $278,325.00 -3.6%0.1%0.6 $2.25 1/31/2023128,300 shares $319,467.00 -29.2%0.1%0.6 $2.49 1/15/2023181,100 shares $420,152.00 -33.3%0.2%0.8 $2.32 12/30/2022271,500 shares $445,260.00 -73.1%0.3%1.4 $1.64 12/15/20221,010,000 shares $1.27 million +6.6%1.0%5.9 $1.26 11/30/2022947,800 shares $1.49 million +2.6%0.9%6.2 $1.57 11/15/2022923,800 shares $1.62 million -1.1%0.9%5.3 $1.75 10/31/2022934,300 shares $1.35 million -4.4%0.9%3.8 $1.45 10/15/2022976,900 shares $1.65 million +2.3%1.0%3.7 $1.69 9/30/2022955,100 shares $1.91 million +4.1%1.0%4 $2.00 9/15/2022917,600 shares $2.14 million -4.6%0.9%3.4 $2.33 8/31/2022961,500 shares $2.37 million -5.7%1.0%3.6 $2.46 8/15/20221,020,000 shares $3.05 million -1.9%1.0%3.6 $2.99 7/31/20221,040,000 shares $2.38 million -4.6%1.0%3.8 $2.29 7/15/20221,090,000 shares $2.51 million -6.8%1.1%3.1 $2.30The “Next Bitcoin”? 10 CENT Crypto Set to Explode (Ad)The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 LIAN Short Interest - Frequently Asked Questions What is LianBio's current short interest? Short interest is the volume of LianBio shares that have been sold short but have not yet been closed out or covered. As of February 29th, investors have sold 378,100 shares of LIAN short. 0.36% of LianBio's shares are currently sold short. Learn More on LianBio's current short interest. What is a good short interest ratio for LianBio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LIAN shares currently have a short interest ratio of 1.0. Learn More on LianBio's short interest ratio. What is a good short interest percentage for LianBio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.36% of LianBio's floating shares are currently sold short. Is LianBio's short interest increasing or decreasing? LianBio saw a drop in short interest in the month of February. As of February 29th, there was short interest totaling 378,100 shares, a drop of 33.5% from the previous total of 568,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is LianBio's float size? LianBio currently has issued a total of 108,063,000 shares. Some of LianBio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. LianBio currently has a public float of 104,770,000 shares. How does LianBio's short interest compare to its competitors? 0.36% of LianBio's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to LianBio: PHAXIAM Therapeutics S.A. (0.01%), Affimed (1.66%), Kinnate Biopharma Inc. (2.01%), NGM Biopharmaceuticals, Inc. (4.52%), Modular Medical, Inc. (0.68%), Protara Therapeutics, Inc. (4.35%), Cyclo Therapeutics, Inc. (0.47%), Fortress Biotech, Inc. (13.02%), Lucid Diagnostics Inc. (2.53%), electroCore, Inc. (0.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short LianBio stock? Short selling LIAN is an investing strategy that aims to generate trading profit from LianBio as its price is falling. LIAN shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against LianBio? A short squeeze for LianBio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LIAN, which in turn drives the price of the stock up even further. How often is LianBio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LIAN, twice per month. The most recent reporting period available is February, 29 2024. More Short Interest Resources from MarketBeat Related Companies: PHXM Short Squeeze AFMD Short Squeeze KNTE Short Squeeze NGM Short Squeeze MODD Short Squeeze TARA Short Squeeze CYTH Short Squeeze FBIO Short Squeeze LUCD Short Squeeze ECOR Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LIAN) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe World's First "$20 Trillion Drug?"Behind the Markets